DZKSiDM.513.96.2024: Performance of specialized laboratory tests: molecular and immunohistochemical tests

This tender, identified by DZKSiDM.513.96.2024, concerns the procurement of specialized laboratory testing services. Specifically, the contract requires the performance of molecular tests and immunohistochemical tests. These advanced diagnostic procedures are crucial for various medical and research applications, enabling precise analysis at the cellular and genetic levels. Molecular testing typically involves examining DNA, RNA, or proteins to detect genetic variations, pathogens, or biomarkers associated with diseases. Immunohistochemistry (IHC) is a technique used to detect specific antigens (proteins) in cells or tissue samples by using antibodies that are labeled with a detectable substance. The successful bidder will be responsible for conducting these tests according to established protocols and quality standards. This procurement is essential for supporting diagnostic capabilities, research initiatives, and potentially personalized medicine approaches within the contracting organization. Further details regarding the scope of work, technical specifications, required qualifications, and evaluation criteria are provided in the full tender documentation.

This is a services contract in the health and medical services sector, with a focus on Laboratory. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.